Compare Genworth Financial Inc Common Stock (GNW) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genworth Financial Inc Common Stock vs Tempus AI — how do they compare? Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.33B), while Tempus AI trades at $66.42 (market cap $12.40B). The key difference: Tempus AI is far larger — about 3.7× Genworth Financial Inc Common Stock's market cap, and Tempus AI is trading nearer its 52-week high, Genworth Financial Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Genworth Financial Inc Common Stock for 0 Days and Tempus AI for 23 Days on average.
| GNW | TEM | |
|---|---|---|
Market Cap | $3.33B | $12.40B |
Volume | 3,324,561 | 6,036,503 |
Sector | Financials | Broad Market / Factor |
52-Week High | $10.60 | $92.45 |
52-Week Low | $7.94 | $41.55 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $2.85B | $13.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.
GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.
Tempus AI (TEM) trades at $68.22, up 0.34% on the day, with a bullish technical signal despite negative profitability. The stock has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent FDA clearance for its ECG-MR AI product and multiple data licensing agreements highlight ongoing business development. Revenue growth is projected from $1.27 billion in 2025 to $1.4 billion in 2026, though net losses persist.
The outlook is supported by strong analyst consensus (64% buy ratings) and a $72.60 price target, suggesting modest upside. Key risks include sustained negative cash flow from operations, high valuation multiples, and insider selling. Investment appeal hinges on the company's ability to translate top-line growth into profitability amid competitive and execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Genworth Financial Inc Common Stock
Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.
Read more on GNW →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
